GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Days Inventory

Notable Labs (Notable Labs) Days Inventory : 0.00 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Notable Labs's Average Total Inventories for the six months ended in Dec. 2023 was $0.00 Mil. Notable Labs's Cost of Goods Sold for the six months ended in Dec. 2023 was $0.20 Mil. Hence, Notable Labs's Days Inventory for the six months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Notable Labs's Days Inventory or its related term are showing as below:

NTBL's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 192.63
* Ranked among companies with meaningful Days Inventory only.

Notable Labs's Days Inventory stayed the same from Dec. 2021 (0.00) to Dec. 2023 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Notable Labs's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.00.


Notable Labs Days Inventory Historical Data

The historical data trend for Notable Labs's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Days Inventory Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Days Inventory
- - -

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Days Inventory - - -

Competitive Comparison of Notable Labs's Days Inventory

For the Biotechnology subindustry, Notable Labs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Notable Labs's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's Days Inventory distribution charts can be found below:

* The bar in red indicates where Notable Labs's Days Inventory falls into.



Notable Labs Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Notable Labs's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0.197*365
=0 / 0.197*365
=0.00

Notable Labs's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

Days Inventory (Q: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2022 ) + Total Inventories (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0.197*365 / 2
=0 / 0.197*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Notable Labs  (NAS:NTBL) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Notable Labs's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Notable Labs's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Notable Labs Days Inventory Related Terms

Thank you for viewing the detailed overview of Notable Labs's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.